Skip to content
OpenCapital
Get started

AIM ImmunoTech AIM Q1 2026 earnings

Reported May 15, 2026 · Before market open

Revenue$22.0KBeat by $11.0KDiluted EPS-$0.69Beat by $0.39
Revenue estimate$11.0K
EPS estimate-$1.08

Next report

Aug 13, 2026 (in a month)
Revenue estimate$100.0K
EPS estimate-$0.17

Versus estimates

Revenue

Q1 2026$22.0KBeat by $11.0K
Q4 2025$21.0KMiss by $79.0KQ3 2025$26.0KQ2 2025$25.0KMiss by $75.0KQ1 2025$16.0KQ4 2024$45.0KMiss by $55.0K

Diluted EPS

Q1 2026-$0.69Beat by $0.39
Q4 2025-$0.44Beat by $0.50Q3 2025-$1.57Miss by $0.59Q2 2025-$3.68Beat by $4.32Q1 2025-$5.00Beat by $3.00Q4 2024-$10.00Miss by $1.00

Ask the moment AIM ImmunoTech reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did AIM ImmunoTech report Q1 2026 earnings?
AIM ImmunoTech (AIM) reported Q1 2026 earnings on May 15, 2026 before market open.
What were AIM ImmunoTech's Q1 2026 revenue and EPS?
AIM ImmunoTech reported revenue of $22.0K and diluted EPS of $-0.69 for Q1 2026.
Did AIM ImmunoTech beat estimates in Q1 2026?
Revenue beat the consensus estimate of $11.0K by $11.0K. EPS beat the consensus estimate of $-1.08 by $0.39.
How did AIM ImmunoTech's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 37.5% from $16.0K a year earlier and diluted EPS grew 86.2% from $-5.00.
Where can I find AIM ImmunoTech's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022499) and the 10-Q periodic report (0001493152-26-023750) directly on SEC EDGAR. The filing index links above go to sec.gov.